Rebuttal to comment on “concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer” Correspondence

  

Authors:	Han, J. E.; Zakeri, K.; Michel, L.; Sherman, E. J.; Lee, N. Y.
Title:	Rebuttal to comment on “concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer”
Keywords:	cancer chemotherapy; treatment outcome; neutropenia; cisplatin; advanced cancer; multimodality cancer therapy; paclitaxel; cancer patient; cancer radiotherapy; radiation dose; combined modality therapy; antineoplastic agent; letter; carboplatin; quality of life; bone marrow suppression; antineoplastic combined chemotherapy protocols; peripheral neuropathy; cetuximab; docetaxel; febrile neutropenia; questionnaire; head and neck cancer; head and neck neoplasms; oropharynx cancer; metastatic breast cancer; head and neck tumor; gothenburg trismus questionnaire; humans; human; musculoskeletal disease assessment; pseudomembranous colitis; european organization for research and treatment of cancer quality of life questionnaire core 30
Journal Title:	Head & Neck
Volume:	46
Issue:	1
ISSN:	1043-3074
Publisher:	John Wiley & Sons, Inc.
Date Published:	2024-01-01
Start Page:	230
End Page:	231
Language:	English
DOI:	10.1002/hed.27560
PUBMED:	37881148
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85174855876&doi=10.1002%2fhed.27560&partnerID=40&md5=bb155ee82c53604b5c1ea1e7f6eddc05
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/212428